Focus
Paxlovid
One in Five Pfizer Drug Users Experience COVID-19 Rebound: Study
Many Paxlovid recipients have suffered from renewed symptoms.
Paxlovid Does Not Work Against 'Long COVID': Study
Out of the 31 long COVID conditions, Paxlovid was found to minimize the incidence of only one.
Pfizer to Charge Nearly $1,400 for COVID-19 Drug Paxlovid
Pfizer projects Paxlovid sales to fall by 58 percent this year compared to 2022.
Study Finds Paxlovid, Molnupiravir Reduce Omicron Hospitalization, Mortality
Researchers said that both oral antiviral drugs can be used to treat nonhospitalized patients at high risk of progressing to severe COVID-19.
